NASDAQ: BTSGBrightspring Health Services Inc Stock
$10.58+0.17 (+1.63%)
Updated Apr 26, 2024
BTSG Price
$10.58
Fair Value Price
N/A
Market Cap
$1.81B
52 Week Low
$7.85
52 Week High
$12.14
P/E
-8.08x
P/B
3.1x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$8.83B
Earnings
-$154.60M
Gross Margin
16.2%
Operating Margin
1.69%
Profit Margin
-1.8%
Debt to Equity
8.41
Operating Cash Flow
$211M
Beta
0.33
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
BTSG Overview
BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. BrightSpring Health Services, Inc. was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. The company was founded in 1974 and is based in Louisville, Kentucky.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BTSG scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BTSG is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BTSG is good value based on its book value relative to its share price (3.1x), compared to the US Health Information Services industry average (3.38x)
P/B vs Industry Valuation
BTSG is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more BTSG due diligence checks available for Premium users.
Be the first to know about important BTSG news, forecast changes, insider trades & much more!
BTSG News
Valuation
BTSG price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-8.08x
Industry
72.49x
Market
41.14x
BTSG price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.1x
Industry
3.38x
BTSG is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
BTSG's financial health
Profit margin
Revenue
$2.4B
Net Income
-$6.5M
Profit Margin
-0.3%
BTSG's Earnings (EBIT) of $149.41M... subscribe to Premium to read more.
Interest Coverage Financials
BTSG's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.5B
Liabilities
$4.9B
Debt to equity
8.41
BTSG's short-term assets ($1.46B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BTSG's long-term liabilities ($3.67B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BTSG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$162.4M
Investing
-$17.0M
Financing
-$143.9M
BTSG's operating cash flow ($210.78M)... subscribe to Premium to read more.
Debt Coverage Financials
BTSG vs Health Information Service Stocks
Brightspring Health Services Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.